Stay updated with breaking news from Nextcure Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
NextCure, Inc. (NASDAQ:NXTC – Get Free Report) was the recipient of a significant decline in short interest in May. As of May 15th, there was short interest totalling 90,500 shares, a decline of 19.5% from the April 30th total of 112,400 shares. Based on an average trading volume of 287,500 shares, the days-to-cover ratio is […]
NextCure, Inc. (NASDAQ:NXTC – Get Free Report) was the recipient of a significant drop in short interest in the month of May. As of May 15th, there was short interest totalling 90,500 shares, a drop of 19.5% from the April 30th total of 112,400 shares. Based on an average daily volume of 287,500 shares, the […]
NextCure (NASDAQ:NXTC – Get Free Report)‘s stock had its “buy” rating reaffirmed by stock analysts at HC Wainwright in a report released on Friday, Benzinga reports. They currently have a $8.00 price target on the stock. HC Wainwright’s target price would suggest a potential upside of 422.88% from the company’s previous close. Separately, Needham & […]
Phase 1b data for NC410 combo with pembro to be presented at ASCO annual meeting on June 1Presented preclinical data from LNCB74 at recent AACR annual meeting Cash of approximately $96.0 million...
Marquette Asset Management LLC acquired a new stake in shares of NextCure, Inc. (NASDAQ:NXTC – Free Report) during the 4th quarter, Holdings Channel.com reports. The firm acquired 58,259 shares of the company’s stock, valued at approximately $66,000. Separately, Acuitas Investments LLC raised its holdings in NextCure by 30.0% during the 4th quarter. Acuitas Investments LLC […]